Choosing nasal devices: a dilemma in clinical practice
- PMID: 36786256
- PMCID: PMC9987488
- DOI: 10.23750/abm.v94i1.13738
Choosing nasal devices: a dilemma in clinical practice
Abstract
Background and aim: Upper airway diseases are frequent and recognize different etiopathogenetic mechanisms, including infection, inflammation, and allergy. Therefore, topical treatments are preferable in comparison with systemic medications. Several delivery devices are available on the market, including nasal drops, syringes, sprays, nebulizers, and douches. However, it is clinically relevant to know the better way to use it.
Methods: The present experience compared five different devices that were tested: i) a nasal dropper, ii) a standard nasal spray device, iii) a mucosal atomization device with a nozzle tip, iv) a nebulizer device, and v) a nasal douche. Saline solution with methylene blue was the marker to evaluate the intranasal distribution.
Results: The findings showed an apparent difference in area distribution among these delivery devices. Conclusion The present experience showed that doctors should choose the most appropriate device for the current disease in clinical practice.
Conflict of interest statement
The authors declare that they have no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.
Figures
References
-
- Benninger M, Ahmad N, Marple BF. The safety of intranasal steroids. Otolaryngol Head Neck Surgery. 2003;129:739–750. - PubMed
-
- FDA Guidance for Industry, Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products - Chemistry, Manufacturing, and Controls Documentation, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research. 2002
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
